Multimodal Imaging and Choroidal Volumetric Changes After Half-fluence PDT in Central Serous Chorioretinopathy

References

• Nicholson B, Noble J, Forooghian F, Meyerle C. Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol 2013;58:103–126
   PubMed Web of Science ®Google Scholar
• Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Ho A, Orlock D. Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol 1994;112:1057–1062
   PubMed Web of Science ®Google Scholar
• Scheider A, Nasemann JE, Lund OE. Fluorescein and indocyanine green angiographies of central serous choroidopathy by scanning laser ophthalmoscopy. Am J Ophthalmol 1993;115:50–56
   PubMed Web of Science ®Google Scholar
• Mrejen S, Spaide RF. Optical coherence tomography: imaging of the choroid and beyond. Surv Ophthalmol 2013;58:387–429
   PubMed Web of Science ®Google Scholar
• Imamura Y, Fujiwara T, Margolis R, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina 2009;29:1469–1473
   PubMed Web of Science ®Google Scholar
• Pryds A, Larsen M. Choroidal thickness following extrafoveal photodynamic treatment with verteporfin in patients with central serous chorioretinopathy. Acta Ophthalmol 2012;90:738–743
   PubMed Web of Science ®Google Scholar
• Yang L, Jonas JB, Wei W. Optical coherence tomography-assisted enhanced depth imaging of central serous chorioretinopathy. Invest Ophthalmol Vis Sci 2013;54:4659–4665
   PubMed Web of Science ®Google Scholar
• Yang L, Jonas JB, Wei W. Choroidal vessel diameter in central serous chorioretinopathy. Acta Ophthalmol 2013;91:e358–e362
   PubMed Web of Science ®Google Scholar
• Yannuzzi LA. Central serous chorioretinopathy: a personal perspective. Am J Ophthalmol 2010;149:361–363
   PubMed Web of Science ®Google Scholar
• Montero JA, Ruiz-Moreno JM. Optical coherence tomography characterisation of idiopathic central serous chorioretinopathy. Br J Ophthalmol 2005;89:562–564
   PubMed Web of Science ®Google Scholar
• Kuroda S, Ikuno Y, Yasuno Y, Nakai K, Usui S, Sawa M, et al. Choroidal thickness in central serous chorioretinopathy. Retina 2013;33:302–308
   PubMed Web of Science ®Google Scholar
• Park SJ, Kim BH, Park KH, Woo SJ. Punctate hyperfluorescence spot as a common choroidopathy of central serous chorioretinopathy and polypoidal choroidal vasculopathy. Am J Ophthalmol 2014;158:1155--1163
   PubMed Web of Science ®Google Scholar
• Balasubramanian M, Bowd C, Vizzeri G, Weinreb RN, Zangwill LM. Effect of image quality on tissue thickness measurements obtained with spectral domain-optical coherence tomography. Opt Express 2009;17:4019–4036
   PubMed Web of Science ®Google Scholar
• Karim SP, Adelman RA. Profile of verteporfin and its potential for the treatment of central serous chorioretinopathy. Clin Ophthalmol 2013;7:1867–1875
   PubMedGoogle Scholar
• Fawzi AA, Holland GN, Kreiger AE, Heckenlively JR, Arroyo JG, Cunningham ET Jr. Central serous chorioretinopathy after solid organ transplantation. Ophthalmology 2006;113:805–813
   PubMed Web of Science ®Google Scholar
• Gass JD. Stereoscopic atlas of macualr diseases: diagnosis and treatment, 4th ed, vol. 1. St. Louis (MO): Mosby, 1997
   Google Scholar
• Sato T, Kishi S, Watanabe G, Matsumoto H, Mukai R. Tomographic features of branching vascular networks in polypoidal choroidal vasculopathy. Retina 2007;27:589–594
   PubMed Web of Science ®Google Scholar
• Fujimoto H, Gomi F, Wakabayashi T, Sawa M, Tsujikawa M, Tano Y. Morphologic changes in acute central serous chorioretinopathy evaluated by fourier-domain optical coherence tomography. Ophthalmology 2008;115:1494–1500, 500
   PubMed Web of Science ®Google Scholar
• Ahlers C, Geitzenauer W, Stock G, Golbaz I, Schmidt-Erfurth U, Prunte C. Alterations of intraretinal layers in acute central serous chorioretinopathy. Acta Ophthalmol 2009;87:511–516
   PubMed Web of Science ®Google Scholar
• van Velthoven ME, Verbraak FD, Garcia PM, Schlingemann RO, Rosen RB, de Smet MD. Evaluation of central serous retinopathy with en face optical coherence tomography. Br J Ophthalmol 2005;89:1483–1488
   PubMed Web of Science ®Google Scholar
• Ferrara D, Mohler KJ, Waheed N, Adhi M, Liu JJ, Grulkowski I, et al. En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy. Ophthalmology 2013;121:719–726
   PubMed Web of Science ®Google Scholar
• Lehmann M, Wolff B, Vasseur V, Martinet V, Manasseh N, Sahel JA, et al. Retinal and choroidal changes observed with ‘En face' enhanced-depth imaging OCT in central serous chorioretinopathy. Br J Ophthalmol 2013;97:1181–1186
   PubMed Web of Science ®Google Scholar
• Marmor MF. New hypotheses on the pathogenesis and treatment of serous retinal detachment. Graefes Arch Clin Exp Ophthalmol 1988;226:548–552
   PubMed Web of Science ®Google Scholar
• Yannuzzi LA, Slakter JS, Gross NE, Spaide RF, Costa DL, Huang SJ, et al. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study 2003. Retina 2012;32:288–298
   PubMed Web of Science ®Google Scholar
• Gass JD. Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol 1967;63:1–139
   PubMed Web of Science ®Google Scholar
• Goktas A. Correlation of subretinal fluid volume with choroidal thickness and macular volume in acute central serous chorioretinopathy. Eye 2014;28:1431--1436
   Google Scholar
• Razavi S, Souied EH, Cavallero E, Weber M, Querques G. Assessment of choroidal topographic changes by swept source optical coherence tomography after photodynamic therapy for central serous chorioretinopathy. Am J Ophthalmolol 2014;157:852–860
   PubMed Web of Science ®Google Scholar
• Sanchez-Cano A, Orduna E, Segura F, Lopez C, Cuenca N, Abecia E, et al. Choroidal thickness and volume in healthy young white adults and the relationships between them and axial length, ammetropy and sex. Am J Ophthalmol 2014;158:574–583
   PubMed Web of Science ®Google Scholar
• Goto S, Gomi F, Ueno C, Nishida K. Reduced-fluence photodynamic therapy for subfoveal serous pigment epithelial detachment with choroidal vascular hyperpermeability. Am J Ophthalmol 2012;154:865–871
   PubMed Web of Science ®Google Scholar
• Maruko I, Iida T, Sugano Y, Furuta M, Sekiryu T. One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy. Retina 2011;31:1921–1927
   PubMed Web of Science ®Google Scholar
• Maruko I, Iida T, Sugano Y, Saito M, Sekiryu T. Subfoveal retinal and choroidal thickness after verteporfin photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol 2011;151:594–603
   PubMed Web of Science ®Google Scholar
• Spaide RF, Hall L, Haas A, Campeas L, Yannuzzi LA, Fisher YL, et al. Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina 1996;16:203–213
   PubMed Web of Science ®Google Scholar